ARCHIVES

ASCO Urges Doubling Cooperative Group Program Budget

This article is from The Cancer Letter archive.

Vol. 36 No. 14 | April 16, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Watson Steps Down As Chancellor at Cold Spring Harbor Laboratory.

October 26, 2007

Cancer Meetings Listed For Next Three Months

June 25, 1993

In Brief: Loberg Resigns From Bristol-Myers Squibb; Bloomfield Heads Cancer Center At Ohio State

February 14, 1997

NCCS Networker Volume 3 Issue 2, Spring 1989

April 13, 1989

Conversation With The Cancer Letter: Seffrin To Retire After Restructuring ACS

January 24, 2014